Results 71 to 80 of about 162 (126)

Endomyocardial fibrosis: a restrictive cardiomyopathy in developing countries. [PDF]

Arch Cardiol Mex, 2021
Vásquez-Rodríguez JF, Medina-Mur RI, Giraldo LE, Juan-Guardela ML, Gelves J, Jaimes CP.   +5 more
europepmc   +1 more source

Abordagem clínica, laboratorial e multimagem da amiloidose cardíaca Clinical, laboratory and multimodality approach to cardiac amyloidosis = Enfoque clínico, de laboratorio y multimagen de la amiloidosis cardiaca

PAJAR - Pan American Journal of Aging Research
A cardiomiopatia (CM) amiloide é causada pela deposição de proteínas insolúveis amiloides. Pode ter causa primária, ser herdada ou secundária. A CM amiloide por transtirretina do tipo selvagem (ATTR wt) e a amiloidose por cadeias leves (AL) são os tipos ...
Costa, Ovídio
doaj  

Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Ramos HR, Sagripanti M, Sandrin Á, Balestrini L, Balestrini V, Balestrini V, Celorrio V, Gigena A, Coll M, Zelaya F, Quiroga Castro W, Conci EC.   +11 more
europepmc   +1 more source

Significant tricuspid regurgitation is associated with adverse outcomes in patients with transthyretin amyloid cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Decotto S, Iroulart JM, Roveda G, Villanueva E, Aguirre MA, Posadas-Martinez ML, Nucifora E, Pizarro R, Pérez de Arenaza D.   +8 more
europepmc   +1 more source

Current status of nuclear cardiology practice in Latin America and the Caribbean, in the era of multimodality cardiac imaging approach: 2022 update. [PDF]

Nucl Med Commun, 2022
Peix A, Mesquita CT, Gutiérrez C, Puente A, Dueñas-C KA, Massardo T, Berrocal I, Astesiano A, Agüero RN, Bañolas R, Hiplan E, Sánchez M, Barreda AM, Gómez VV, Fernández C, Portillo S, Herrera Y, Mendoza A, Kapitan M, Castellanos C, Rodríguez DI, Estrada E, Páez D.   +22 more
europepmc   +1 more source

[In response to: The hospitalized patient with severe aortic stenosis]. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Bohórquez-Rivero JJ, Parra-Sánchez PA, Roa-Bocanegra AM.   +2 more
europepmc   +1 more source

Monoclonal gammopathy progressing to systemic amyloidosis with cardiac involvement. A case report. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Valenzuela-Rodríguez G, Araoz Tarco O, Fernández Vertiz I.   +2 more
europepmc   +1 more source

[Endomyocardial fibrosis: case report]. [PDF]

Arch Cardiol Mex
Merubia-Navia CI, Ávalos-García Y, Flores-Méndez ET, Morelos-Guzmán M.   +3 more
europepmc   +1 more source

Significant valvular heart disease in wild-type transthyretin amyloidosis: prevalence and impact on survival. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Decotto S, Domenech P, Touzas P, Aguirre MA, Nucifora E, Posadas-Martínez ML, Blanco R, Falconi M, Pizarro R, Pérez de Arenaza D.   +9 more
europepmc   +1 more source

[Arrhythmias and Sudden Death Risk in Hypertrophic Cardiomyopathy]. [PDF]

Arch Peru Cardiol Cir Cardiovasc, 2020
Salinas-Arce J, Gonzales-Luna AC, Cabrera-Saldaña M, Mendoza-Novoa P, Alca-Clares R, Solorzano-Altamirano P, Carpio-Muñoz FD.   +6 more
europepmc   +1 more source